Clinical Report: Attitudes and Perspectives of Pediatric Hematology-Oncology Physicians on AI

Overview

A study of pediatric hematology-oncology physicians in Saudi Arabia reveals that 74.2% support the integration of artificial intelligence (AI) in clinical practice. Concerns regarding ethical issues and the role of human decision-making were also noted.

Background

The integration of artificial intelligence (AI) into healthcare is gaining traction in Saudi Arabia among pediatric hematology-oncology physicians. This field addresses complex diseases, where AI can potentially enhance early diagnosis and treatment strategies. Understanding physician attitudes towards AI is crucial for its implementation in clinical settings.

Data Highlights

Key Findings

• 74.2% of physicians have a positive view of AI integration in clinical practice.
• Significant associations were found between attitudes and physicians' professional title (p = 0.011) and years of experience (p = 0.019).
• Major advantages of AI include efficiency, accuracy, and cost-effectiveness, reported by 74.2% of participants.
• Privacy, interpretability, and ethical concerns were identified as main challenges.
• 56.8% of physicians believe human physicians should remain primary decision-makers when using AI.

Clinical Implications

Ensuring human oversight in AI-assisted decision-making is essential for maintaining clinical integrity.

Conclusion

Pediatric hematology-oncology physicians in Saudi Arabia recognize the potential of AI to enhance clinical practice.

Related Resources & Content

1. Journal of Medical Internet Research (JMIR), 2026 -- Attitudes and Needs of Health Care Providers Toward Artificial Intelligence–Assisted Pediatric Palliative Care: Mixed Methods Study
2. DIGITAL HEALTH, 2026 -- Artificial intelligence in Malaysian health practice: Perspectives from allied health professionals
3. The ASCO Post, 2026 -- Physician-Complementing Artificial Intelligence in Oncology
4. npj Digital Medicine — Toward governance of artificial intelligence in pediatric healthcare
5. WHO guidance on AI ethics and governance
6. ASCO Advocates for Regulated AI Integration in Cancer Care
7. ASCO and AI in Oncology: Rooted in Human-Centered Care - The ASCO Post
8. ESMO basic requirements for AI-based biomarkers in oncology (EBAI) - PubMed
9. The first ESMO guidance for AI-based biomarkers
10. Data protection and cybersecurity laws in Saudi Arabia
11. Guide to the Saudi
12. Health Insurance Council Urges Accredited Service Providers to Register on SDAIA Platform
13. Open Data - Open Data Policy Sectorial Health AI & Data Management Office
14. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation - PubMed
15. Application of artificial intelligence in paediatric oncology imaging | Pediatric Radiology | Springer Nature Link
16. Predicting molecular subtypes of pediatric medulloblastoma using MRI-based artificial intelligence: A systematic review and meta-analysis - PubMed
17. Artificial intelligence and radiomics for pediatric brain tumor classification and molecular characterization: a systematic review - PubMed
18. Frontiers | Development of intelligent tools to predict neuroblastoma risk stratification and overall prognosis based on multiphase enhanced CT and clinical features
19. The current state, challenges, and future directions of artificial intelligence in healthcare in Saudi Arabia: systematic review - PMC
20. Frontiers | Role of artificial intelligence in pediatric intensive care: a survey of healthcare staff perspectives in Saudi Arabia
21. The Council of Health Insurance Launches Its 2025–2027 Strategy
22. National E- Health Strategy - Strategy Guiding Principles